Yvonne Maldonado
Academic Appointments
- Professor, Pediatrics - Infectious Diseases
- Professor (By courtesy), Health Research & Policy
Contact Information
-
Clinical Offices
Medicine Specialties Clinic 730 Welch Rd 2nd Floor Palo Alto, CA 94304 Tel Work (650) 736-7642 Fax (650) 725-8040Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
Professional Snapshot
Clinical Focus
- Infectious Diseases, Pediatric
- Pediatric Infectious Disease
Professional Education
| Board Certification: | General Pediatrics, American Board of Pediatrics (1986) |
| Fellowship: | Centers For Disease Control, GA (1988) |
| Fellowship: | Johns Hopkins University, MD (1986) |
| Residency: | Johns Hopkins University, MD (1984) |
| Internship: | Stanford University School of Medicine, CA (1982) |
Postdoctoral Advisees
Candice McNeil , Ali Rowhani Rahbar , Amy Sturt , Stephanie Troy
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Merck |
Scientific Focus
Current Research Interests
The research I have conducted has been focused on epidemiologic aspects of viral vaccine development and prevention of perinatal HIV transmission. A major project has been to identify the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) among children living in developing areas of the world, where OPV immunogenicity is poor. We have identified several factors which affect the poor immunogenicity of OPV and will conduct clinical studies to attempt to improve immunogenicity. We are now working on ways to understand the transmission and circulation of polio vaccine derived viruses, which may cause polio, and how to use this information in global eradication of polio. I also work on perinatal HIV infection, including strategies to prevent breastfeeding transmission in developing settings as well as understanding how to maximize prevention strategies among pregnant women in developed countries.
A second recent project has been to define the ontogeny of the immune response to measles vaccine among young infants. The purpose is to identify specific humoral and cell-mediated immune responses to measles vaccine which affect vaccine immunogenicity and induce the immunosuppressive effects associated with measles vaccination.
A final project I have conducted since 1989 involves a long term natural history study of infants with perinatal HIV exposure and infection. This computer-based study involves following all HIV-exposed and infected infants living in the Northern California and defining factors associated with progression of HIV-related disease.
Publications
- Prenatal screening for infectious diseases: an analysis of disparities and adherence to policy in California. Matern Child Health J. 2009; (2): 260-7
- Impact of fetal and neonatal viral (and parasitic) infections on later development and disease outcome. Nestle Nutr Workshop Ser Pediatr Program. 2008: 225-42
- Patient acceptance of and satisfaction with rapid HIV Testing in a Labor and Delivery Setting. J Womens Health (Larchmt). 2008; (3): 465-71
- Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay. J Clin Microbiol. 2007; (8): 2419-25
- The effectiveness of state and national policy on the implementation of perinatal HIV prevention interventions. Am J Public Health. 2007; (6): 1041-6
Help